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Abstract Lysyl oxidase ゅLOXょ is a secreted copper┽dependent amine oxidase whose primary function is to drive collagen crosslinking and extracellular matrix stiffness┻ LOX in colorectal cancer ゅCRCょ synergizes with hypoxia┽inducible factor┽な ゅ()F┽な฀ to promote tumor progression┻ (ere we investigated whether LOX【()Fな endows CRC cells with full competence for aggressive colonization in bone┻ We show that a high LOX expression in primary tumors from CRC patients was associated with poor clinical outcome┸ irrespective of HIF-1┻ Additionally┸ LOX was expressed by tumor cells in the bone marrow from CRC patients with bone metastases┻ In vivo experimental studies show that 
LOX overexpression in CRC cells or systemic delivery of the conditioned medium from 
LOX┽overexpressing CRC cells promoted tumor cell dissemination in the bone marrow and enhanced osteolytic lesion formation┸ irrespective of HIF-1┻ Conversely┸ silencing or pharmacological inhibition of LOX activity blocked dissemination of CRC cells in the bone marrow and tumor┽driven osteolytic lesion formation┻ In vitro┸ tumor┽secreted LOX supported the attachment and survival of CRC cells to and in the bone matrix┸ and inhibited osteoblast differentiation┻ LOX overexpression in CRC cells also induced a robust production of )L┽は┻ )n turn┸ both LOX and )L┽は were acting in concert to promote RANKL┽dependent osteoclast differentiation┸ thereby creating an imbalance between bone resorption and bone formation┻ Collectively┸ our findings show that LOX supports CRC cell dissemination in the bone marrow and they reveal a novel mechanism through which LOX┽driven )L┽は production by CRC cells impairs bone homeostasis┻  
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Introduction  The lysyl oxidase ゅLOXょ family of secreted copper┽dependent amine oxidases consists of five paralogs┺ LOX and LOX┽like な┽ね ゅLOXL な┽ねょ┻ The primary function of the LOX family is to catalyse the covalent crosslinking of collagen and elastin in the extracellular matrix┸ thereby increasing insoluble matrix deposition and tensile strength ゅなょ┻ )ncreased expression of LOX and LOXL2 has been consistently reported in various cancer types ゅcolorectal┸ breast┸ prostate┸ lung┸ bladderょ ゅな┽のょ┻ LOX and LOXLに are closely associated with desmoplastic areas at the invasive front of infiltrating tumors ゅなょ┻ They mediate collagen【elastin crosslinking that increases extracellular matrix stiffness┸ a process which is associated with enhanced integrin┽mediated mechanotransduction coupled to increased tumor cell invasion in breast and colorectal cancers ゅな┸ぬ┸はょ┻ LOX┽ and LOXLに┽mediated collagen crosslinking are also responsible for enhancing outgrowth in metastatic xenograft models of breast cancer ゅの┸ばょ┻ Additionally┸ LOX enhances the metastatic trait of breast tumor xenografts in animals by stimulating 
TWIST1 transcription in tumor cells ゅぱょ┻ )n the same vein┸ hypoxia┽inducible factor┽な ゅ()F┽なょ induces the expression of several members of the LOX family in breast cancer cells┸ including LOX and LOXL2┸ which then catalyses collagen crosslinking in the lungs┸ facilitating the recruitment of bone marrow┽derived cells and the subsequent colonization of the pulmonary tissue by tumor cells ゅの┸ ひ┽ななょ┻ Furthermore┸ we have shown that LOX synergizes with ()F┽な in promoting in vivo growth of colorectal tumors ゅにょ┻ These experimental results ゅに┸ ぬ┸ の┽ななょ probably explain why increased expression of LOX and LOXL2 in primary tumors ゅcolorectal┸ breast┸ lung┸ prostateょ is associated with distant relapse and poor survival ゅなょ┻ )ndeed┸ targeting of LOX and LOXLに with the LOX inhibitor β┽aminoproprionitrile ゅβAPNょ or function┽blocking antibodies ゅABどどにぬ┸ GSぬねなょ┸ respectively┸ is efficacious at reducing metastatic tumor burden in xenograft 
 の
models of cancer ゅば┸なに┸なぬょ┻ Thus┸ there is a body of experimental evidence indicating that LOX and LOXLに facilitate the development of metastases in distant organs┸ such as the lungs┸ liver┸ and brain┻ Surprisingly┸ little is known regarding the role of LOX proteins during bone metastasis formation┻   )n bone metastasis┸ metastatic cancer cells residing in the bone marrow alter the functions of bone┽resorbing ゅosteoclastsょ and bone┽forming ゅosteoblastsょ cells and hijack signals coming from the bone matrix ゅなねょ┻ By disrupting the physiological balance between bone resorption and bone formation┸ metastatic cells therefore promote skeletal destruction┻ The detection rate of disseminated tumor cells ゅDTCょ in the bone marrow from colorectal cancer ゅCRCょ patients receiving curatively intended surgery is にばガ and their presence is associated with a poor clinical outcome ゅなの┸なはょ┻ This detection rate is relatively high and comparable to what is observed in bone┽tropic cancers such as breast cancer ゅabout ぬどガょ ゅなのょ┸ which is in intriguing contrast to the low incidence of overt bone metastases in CRC ゅなばょ┻ A current hypothesis gaining ground is that DTCs may be representative of dormant tumor cells with the ability to escape dormancy upon receiving appropriate stimuli from the microenvironment ゅなぱょ┻ Given the role of LOX in driving collagen crosslinking and extracellular matrix stiffness ゅなょ┸ we hypothesized that LOX in CRC may be one of the factors that endow DTCs with full competence for aggressive colonization in bone┻ )nterestingly┸ it has been very recently shown during the course of this study that hypoxia┽induced LOX in breast cancer cells generates premetastatic osteolytic lesions in animals through the stimulation of NFATcな┸ a master regulator of osteoclastogenesis ゅなひょ┻ (ere┸ we investigated the role of LOX and its regulator ()F┽なα in CRC bone metastases┻   
 は
Materials and Methods 
Reagents, human CRC cell lines, and animals. All chemicals were obtained from Sigma┽Aldrich ゅBuchs┸ Switzerlandょ┸ unless otherwise specified┻ Primer pairs used for quantitative real┽time PCR analysis are listed in Supplementary Table Sな┻ (uman CRC cell lines were obtained from the ATCC い(ctななは and (Tにひ ゅyear にどどばょ┹ LSなばねTr ゅyear にどどひょう┻  They were tested for authentication by DNA fingerprinting using short tandem repeat ゅSTRょ method in にどなど┻ The mutation in the ras proto┽oncogene was tested in にどなね┻ (ctななは cells were maintained in RPM)┽なはねど┽Glutamax ゅ)nvitrogenょ with などガ ゅv【vょ fetal calf serum ゅFCSょ ゅLife technologies┸ Carlsbad┸ CA┸ USAょ┸ などmM (EPES┸ なmM sodium pyruvate┸ and ど┻なmM non essential amino acids ゅ)nvitrogenょ at ぬば ソC┻ (Tにひ and LSなばねTr cells were grown in DMEM┽glutamax ゅ)nvitrogenょ┸ などガ ゅv【vょ FCS and のどづg【ml gentamycin┻ These cells were first transduced with lentiviral shRNA particles targeting 
LOX ゅshLOXょ or a control sequence ゅshCTLょ then co┽transduced with particles containing an empty vector ゅEVょ or a LOX┽expressing vector ゅLOXギょ under the control of a doxycycline ゅdoxょ┽inducible promoter┸ as previously described ゅにょ┻ Transduced cell lines initially called shCTL【EV┸ shLOX【EV ゅcells silenced for endogenous LOXょ and shCTL【LOXギ ゅcells overexpressing LOX in an inducible mannerょ ゅにょ were named┸ respectively┸ Ctrl┸ LOX┽ and LOXギ for brevity┻ Additionally┸ Ctrl and LOXギ (ctななは cells were co┽transduced with lentiviral shRNA particles targeting HIF-1a ゅCtrl【()Fなα┽ and LOXギ【()Fなα┽┸ respectivelyょ┸ as previously described ゅにょ┻   Four┽week┽old female Balb【c immunocompromised mice were purchased from Janvier ゅSaint┽Berthevin┸ Franceょ┻ Animals were maintained in a なに┽h light┽dark cycle and given free access to food and water┻ All procedures involving animals┸ including their housing and care┸ the method by which they were culled┸ and experimental 
 ば
protocols were conducted in accordance with a code of practice established by the local ethical committee of the University of Lyon┻ 
Immunohistochemistry. CRC tissue specimens ゅprimary tumors and bone metastasesょ were obtained from the Department of Pathology┸ (ospices Civils de Lyon┻ Tumor sections ゅのヅmょ were de┽paraffinized┸ treated with pepsin for なの┽min at ぬばソC ゅZymed┸ )nvitrogenｋ Carlsbad USAょ┸ and processed for immunohistochemical staining using a LOX antibody ゅな┺にのど dilution┹ abぬなにぬぱ Abcamょ┻  
LOX activity measurement. LOX activity was measured using a fluorescent assay┸ according to manufacturer╆s instructions ゅabななになぬひ Abcamょ┻  
ELISA. Conditionned media from LOX┽ and LOXギお(ctななは were collected┸ and )L┽は was measured by EL)SA┸ according to  manufacturer╆s instructions ゅClinisciencesょ┻  
Protein extraction and Western blotting. Proteins were extracted in R)PA buffer┸ electrophoresed on a SDS┽polyacrylamide gel ゅLife technologiesょ┸ then transferred onto nitrocellulose membranes ゅMillipore┸ Billerica┸ MAょ and proteins were probed with a primary antibody against STATぬ ゅ(Pなどどなはばな┸ な┺ぬどど dilution┸ Sigmaょ┸ STATぬYばどの ゅひなねの┸ な┺な┸どどど dilution┸ Cell Signalingょ┸ Src ゅになにぬ┸ な┺な┸どどど dilution┸ Cell Signalingょ┸ SrcYねなは ゅはひねぬ┸ な┺な┸どどど dilution┸ Cell Signalingょ┸ FAK ゅどの┽のぬば┸ な┺な┸どどど dilution┸ Upstateょ┸ FAKYどにの ゅぬにぱね┸ な┺な┸どどど dilution┸ Cell Signalingょ┸ Akt ゅひにばに┸ な┺な┸どどど dilution┸ Cell Signalingょ┸ AktTぬどぱ ゅねどのは┸ な┺な┸どどど dilution┸ Cell Signalingょ┸ tubulin ゅTのなはぱ┸ な┺に┸どどど dilution┸ Sigmaょ or GAPD( ゅabひねぱの┸ な┺に┸のどど dilution┸ Abcamょ┻ After incubation with primary antibodies┸ membranes were incubated with horseradish peroxide ゅ(RPょ┽conjugated secondary goat anti┽mouse ゅな┺に┸どどど dilution┸ BioRadょ or goat anti┽rabbit ゅな┺に┸のどど dilution┸ BioRadょ 
 ぱ
antibody┻ )mmunostaining was performed with enhanced chemiluminescence ゅECLょ detection system ゅPerkin Elmerょ┻  
Functional cell-based assays┻ Ctrl┸ LOX┽ and LOXギ (ctななは cells ゅねxなどは【mlょ┸ treated or not treated with ぬのどµM βAPN or などど µg【ml tocilizumab ゅRoactemra┸ Rocheょ┸ were cultured for ねぱh in complete RPM) medium without phenol red┻ Conditioned media were then collected┸ centrifuged and stored as aliquots at ┽ぱどソC until used┻ LOX production was analyzed by western blotting┸ as previously described ゅにょ┻   For cell adhesion assays┸ experiments were conducted as previously described ゅにどょ┻ Briefly┸ ひは┽well tissue culture plates were coated with increasing concentrations of type┽) collagen or fibronectin ゅど┻どなmg【cmに to などどmg【cmにょ and incubated overnight at ねソC┻ Cells ゅねケなどね cells【ど┻な ml【wellょ were starved for なは hours then plated to extracellular matrix proteins for はど min at ぬばソC in a のガ COに atmosphere┻ After washing┸ adherent cells were fixed and stained with ど┻なガ ゅw【vょ crystal violet┻ The dye was eluted with にガ ゅw【vょ SDS and the optical density quantified at のひの nm┻ Alternatively┸ ひは┽well tissue culture plates were coated with rat tail type┽) collagen ゅなの µg【cmにょ overnight at ねソC┻ Following incubation with なガ BSA for ぬど min┸ cells ゅなケなどの cells【ど┻な ml【wellょ were incubated for なh at ぬばソC in a のガ COに atmosphere┻ After washing┸ adherent cells were fixed and stained with hematoxylin and fuschin┻  For tumor spheroid┽formation assays┸ なxなどね【ど┻ぬ ml (ctななは cells ゅCtrl┸ LOX┽ and LOXギょ were seeded in CytoCapture Chambers┸ Big (exagonal Cavities ゅdiameter にのどヅmょ ゅPAAょ┻ Cells were grown in suspension in ど┻ぬmL of MammoCultTM basal medium containing などガ ゅv【vょ MammoCultTM proliferation supplement ゅStem Cellょ┸ ど┻どどどねガ ゅw【vょ heparin ゅStem Cellょ┸ なヅg【mL hydrocortisone┸ なmM glutamine┸ のどU【mL penicillin┸ のどヅg【mL streptomycin ゅLife Technologiesょ┸ with or without ぬのどヅM șAPN┻ After の days 
 ひ
in culture┸ tumor spheroids were imaged under a microscope ゅConfocal┽Leica SPの Xょ and quantified using Fiji software┻ Spheroids of at least はどヅm in diameter were counted┻  
Osteoclastogenesis assay. Experiments were conducted as described previously ゅになょ┻ Briefly┸ bone marrow cells from は┽week┽old OFな mice were cultured for ば days in α┽MEM medium ゅ)nvitrogenょ supplemented with などガ ゅv【vょ FCS┸ にど ng【ml M┽CSF ゅR┃D Systemsょ and にどど ng【ml RANKL┸ alone or in combination ゅfrom day な to day ばょ with the conditioned media from transduced (ctななは cells ゅCtrl┸ LOXギ and LOX┽ょ ゅにの µg【mlょ or with recombinant LOX ゅなのど ng【mlょ┻ After ば days in culture┸ mature osteoclasts were enumerated under a microscope on the basis of the number of nuclei ゅmore than three nucleiょ and TRAP activity┻  
NFATc1 staining.  Cultured osteoclasts on coverslips were fixed for なの min in ねガ PFA then permeabilized with ど┻なガ Triton X┽などど in PBS for など min┻ Saturation was performed with のガ normal goat serum in ど┻なガ PBS┽Tweenにど ゅNGSょ for にh┻ Monoclonal antibody to NFATcな ゅSC┽ばにひね┸ Santa Cruzょ┸ diluted な┺などど in NGS┸ was incubated なh at room temperature and┸ after washing┸ coverslips were further incubated for another なh with a secondary goat anti┽mouse antibody coupled to Alexa Fluor ねぱぱ ゅな┺ぬどど dilution in PBSょ┻ Coverslips were then mounted in FluorSave Reagent ゅCalbiochemょ┻ 
Osteoblastogenesis assay. Experiments were conducted as previously described ゅににょ┻ Briefly┸ calvaria of ぬ┽day┽old OF┽な mice were dissected then cells were enzymatically isolated by sequential digestion with collagenase and plated into にね┽well plates┻ After にね-h incubation┸ ゎ┽MEM medium containing などガ ゅv【vょ FCS was changed and supplemented with のどづg【ml ascorbic acid and with or without conditioned medium from transduced (ctななは cells ゅCtrl┸ LOXギ and LOX┽ょ┻ Medium was changed every other 
 など
day for にな days┻ などmM sodium が┽glycerophosphate was added for the last week of the experiments┻ At day にな┸ bone mineralized nodules were fixed and stained with von Kossa staining┻  
Animal studies. CRC cell lines ゅのxなどの cells in などど µl PBSょ were inoculated intra┽arterially into anesthetised female Balb【c nude mice┻ When specified┸ ぬどど µl of conditioned medium from transduced (ctななは cells were intraperitoneally injected daily into mice┻ For LOX inhibition┸ animals were treated with ど┻にガ ゅw【vょ βAPN┸ supplied in the drinking water┻ For blockade of )L┽は receptor┸ animals were treated every other day with tocilizumab ゅのど mg【kg┸ i┻p┻ょ┻ The progression of skeletal tumor burden was monitored by whole┽body bioluminescence imaging ゅNightOwl┸ Berthold Technologiesょ┸ following subcutaneous administration of luciferin ゅなどど mg【kg in PBS┹ Promegaょ など min prior to imaging┻ The progression of osteolytic lesions in the skeleton of anesthetised animals was monitored by radiography┸ using a cabinet X┽ray system ゅMX┽にど┹ Faxitron X┽ray Corporationょ┻ The area of osteolytic lesions was measured using Explora┽Nova Morpho Expert software┻ Animals were sacrificed on day ば or ぬの after tumor cell inoculation┸ and hind limbs were collected for histology and histomorphometric analyses┻ 
Bone histology and histomorphometry. Bone histology and histomorphometric analysis of bone tissue sections were performed on decalcified┸ の┽づm bone┽tissue sections stained with Goldner╆s Trichrome┸ as previously described ゅになょ┻ For histomorphometric measurements┸ the bone volume ゅBVょ【tissue volume ゅTVょ and tumor volume ゅTuVょ【soft tissue volume ゅSTVょ ratios represent the percentages of bone and tumor tissue┸ respectively┻ Additionally┸ osteoclasts within bone tissue sections 
 なな
were stained using a TRAP activity kit assay┻ The resorption surface ゅOc┻S【BSょ was calculated as the ratio of TRAP┽positive trabecular bone surface ゅOc┻Sょ to the total bone surface ゅBSょ using the image analysis system MorphoExpert ゅExplora┽novaょ┻ 
Ex vivo micrometastasis experiments. Ex┽vivo micrometastasis experiments were conducted as previously described ゅになょ┻ Animals were culled on day ば or day ぬの after tumor cell inoculation┻ (ind limbs were collected and tibiae and femurs were minced then soaked in an enzyme cocktail containing ぬどどU【ml type┽) collagenase and などど U【ml hyaluronidase ゅStemCell Technologiesょ in DMEM medium for に hours at ぬばソC┻ After incubation┸ bone marrow cell suspensions were seeded in は┽well plates and cultured in complete medium┻ After な┽day┸ cultured cells were placed under puromycin selection for に weeks┸ enabling the selective outgrowth of antibiotic┽resistant tumor cells┻ Tumor cell colonies were then fixed┸ stained with ど┻のガ ゅv【vょ crystal violet and counted┻ 
Clinical correlation analyses. Gene expression data and clinical annotations were downloaded from The Cancer Genome Atlas for colorectal cancer and previously published datasets downloaded from the Gene Expression Omnibus ゅGSEなはなにの┸ GSEぬぬななぬ┸ GSEねなにのぱ┸ GSEなばのぬは┸ GSEぬなのひの┸ GSEなにひねのょ ゅsee Supplementary Table Sにょ┻  
Statistical Analysis. All experimental data are presented as mean values グ SD┻ Statistical comparisons of values were made using the Mann┽Whitney U┽test┻ Disease┽free survival Kaplan Meier analyses were performed using the log┽rank ゅMantel┽Coxょ test┻ Correlation analyses were performed by the Spearman Rank test and the Pearson correlation┻ All tests were two┽sided┸ and P values less than ど┻どの were considered statistically significant┻ 
 なに
Results 
LOX expression in colorectal cancer is clinically associated with poor prognosis.  As a first step towards evaluating the role of LOX and its regulator ()F┽なα in CRC bone metastases┸ we conducted a meta┽analysis in a cohort of CRC patients ゅn サ ののにょ and found that high LOX expression in primary tumors was associated with poor overall survival ゅp サ ど┻どなどひょ and poor relapse┽free survival ゅp サ ど┻どにょ ゅSupplementary Figs┻ Sなa and Sなbょ┻ Additionally┸ high LOX expression was a negative determinant of relapse┽free survival┸ irrespective of HIF-1α levels ゅSupplementary Fig┻ Sなcょ┻ Using immunohistochemistry with a anti┽LOX antibody┸ we examined の CRC patients with bone metastases┸ including ぬ patients for whom we had pairs of primary tumors and their matching bone metastases┻ Although all of the matching primary and metastatic tumors expressed LOX┸ there was a preferrential moderate┽to┽strong staining for LOX associated with the carcinoma cells in bone metastases for all の patients ゅFig┻ な and Supplementary Fig┻ Sなdょ┻ 
 
Tumor-secreted LOX in colorectal cancer generates osteolytic lesions in animals.  
 We next investigated the role for LOX and ()F┽なα in CRC bone metastasis formation┸ using human (ctななは cells ゅCtrlょ previously transduced for ()F┽なα silencing ゅCtrl【()F┽なα┽ょ and【or LOX overexpression ゅLOXギ ┹ LOXギ【()F┽なα┽ょ ゅにょ┻ Compared to Ctrl and Ctrl【()F┽なα┽ tumor┽bearing animals┸ bioluminescent LOXギ (ctななは cells were readily detected in the hind limbs of animals at day ぬな┽post injection┸ irrespective of 
HIF-1 expression ゅFig┻ にaょ┻ Additionally┸ there was a similar effect on osteolytic lesions in LOXギ and LOXギ【()F┽なα┽ tumor┽bearing animals and the extent of lytic lesions was に┻の┽fold higher than that of animals bearing Ctrl┽ or Ctrl【()F┽なα− tumors ゅFig┻ にbょ┻ 
 なぬ
(ence┸ these data indicated that tumor┽secreted LOX promotes osteolytic lesion formation in vivo, irrespective of HIF-1α expression┻   To further address the role of LOX in osteolytic lesion formation┸ we used two additional previously published human CRC cell lines ゅ(Tにひ and LSなばねTrょ in which LOX expression has been overexpressed or silenced ゅにょ┻ The modulation of LOX expression did not affect the expression of other members of the LOX┽like family ゅSupplementary Table Sぬょ┻ We observed that LOX┽overexpressing (cななは┸ (Tにひ and LSなばねTr cells caused osteolytic lesions in animals at day ぬの┽post injection ゅFig┻ にcょ┻ The extent of osteolytic lesions in LOXギ tumor┽bearing animals was ぬ┽ to の┽fold higher than that of animals bearing Ctrl or LOX┽ tumors ゅFig┻ にcょ┻  Additionally┸ the treatment of LOXギ (ctななは tumor┽bearing animals with the LOX inhibitor βAPN for ぬの days┸ prolonged bone metastasis┽free survival to a level similar to that observed with animals bearing LOX┽ or Ctrl┽(cななは tumors ゅSupplementary Fig┻ Sにょ┻ (istomorphometric analysis of hind limbs with metastases from animals bearing (ctななは tumors showed that the BV【TV ratio ゅa measure of the bone volumeょ was decreased in LOXギ tumor┽bearing animals┸ compared with LOX┽ and Ctrl tumor┽bearing animals ゅFig┻ にd and Table なょ┻ This difference was accompanied with a substantial increase in the TRAP staining of bone tissue sections of metastatic legs from LOXギ tumor┽bearing animals ゅindicating a stimulation of active┽osteoclast resorption surfacesょ ゅFig┻ にd and Table なょ┻ Additionally┸ there was a dramatic increase in the TuV【STV ratio ゅa measure of the skeletal tumor burdenょ in LOXギ tumor┽bearing animals┸ compared with animals bearing Ctrl┽ and LOX┽ tumors ゅFig┻ にd and Table なょ┻   To further examine LOX┽dependency┸ nude mice were treated with the conditioned medium from LOXギ or LOX┽ (ctななは cells beginning な day ゅD┽なょ before intra┽arterial inoculation of parental (ctななは cells ゅDどょ┻ The daily treatment with the conditioned 
 なね
medium then continued until day ぬの ゅDぬのょ┸ at which time anesthetised animals were analysed by radiography ゅFig┻ ぬaょ┻ Radiographs of animals showed that mice treated with the LOXギ conditioned medium had a は┽fold increase in the extent of osteolytic lesions┸ compared to that observed with the LOX┽ medium ゅFigure ぬbょ┻ The bone marrow of ぬ metastatic mice per group was then collected and placed in culture under antibiotic selection┸ enabling the selective outgrowth of antibiotic┽resistant tumor cells ゅFig┻ ぬcょ┻ The average number of colonies recovered from the bone marrow of mice treated with the LOXギ conditioned medium was に┻の┽fold higher than that recovered from animals treated with the LOX┽ conditioned medium ゅぬねね グ はど vs なにな グ にの colonies【wellょ ゅP サ ど┻どぱょ ゅFig┻ ぬcょ┻ (ence┸ LOX plays a prominent role in supporting osteolytic lesion formation in vivo and tumor cell dissemination ex vivo┻  
LOX disrupts the balance between bone resorption and bone formation.  By disrupting the physiological balance between bone resorption and bone formation┸ tumor  cells promote skeletal destruction ゅなねょ┻ To directly test whether LOX expression in (ctななは cells could influence osteoclast differentiation┸ we treated primary mouse bone marrow cell cultures with RANKL and M┽CSF together with the conditioned medium from Ctrl┸ LOX┽ and LOXギ cancerous cells┻ Consistent with in vivo data ゅFig┻ にdょ┸ the conditioned medium from LOXギ (ctななは cells stimulated the formation of TRAP┽positive multinucleated osteoclasts┸ compared to conditioned media from Ctrl┽ and LOX┽ (ctななは cells ゅFig┻ ねaょ┻ As aforementioned┸ βAPN treatment of LOXギ tumor┽bearing animals inhibited osteolysis ゅSupplementary Fig┻ Sにょ┻ Similarly┸ βAPN almost completely inhibited LOX enzymatic activity in the conditioned medium from LOXギ (ctななは cells┸ compared to that observed with the conditioned medium from LOX┽ (ctななは cells ゅSupplementary Fig┻ Sぬょ┻ Additionally┸ βAPN blocked the stimulatory effect of LOXギ on 
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osteoclastogenesis ゅFig┻ ねaょ┸ indicating that the promoting effect of LOX on RANKL┽dependent osteoclastogenesis critically depends on its enzymatic activity┻    LOX overexpression induced a robust production of )L┽は by (ctななは cells┸ whose production was almost totally inhibited by βAPN treatment ゅFig┻ ねbょ┻ Tumor┽derived )L┽は can act as an autocrine agent and activate the signal transducer and activator of transcription ぬ ゅSTATぬょ signalling pathway in CRC cells ゅにぬ┸にねょ┻ )n agreement with these findings ゅにぬ┸ にねょ┸ STATぬ phosphorylation levels were substantially increased in LOXギ(ctななは cells┸ compared to Ctrl┽ and LOX┽ (ctななは cells ゅFig┻ ねcょ┻ Additionally┸ blockade of the )L┽は receptor by tocilizumab abrogated STATぬ phosphorylation in LOXギ(ctななは cells┸ compared with untreated cells ゅFig┻ ねcょ┻ Thus┸ our data revealed a previously unreported functional link between LOX and )L┽は┸ in which LOX┽driven )L┽は production by CRC cells promotes )L┽はR【STATぬ signaling pathway┻ This link extended to the clinic┸ because LOX and IL-6 significantly correlated across ば publically available databases on CRC┸ when analysed independently or in combination ゅFig┻ ねd and Supplementary Fig┻ Sねょ┻ The addition of )L┽は to the conditioned medium of LOX┽ (ctななは cells stimulated osteoclast formation to an extent similar to that observed with the conditioned medium from LOXギ (ctななは cells ゅFig┻ ねeょ┻ Moreover┸ tocilizumab inhibited osteoclastogenesis induced by the LOXギ conditioned medium┸ and an additive inhibitory effect on osteoclast formation was observed when combining tocilizumab and βAPN ゅFig┻ ねfょ┻ These results ゅFig┻ ねe┽fょ suggested that both )L┽は and LOX were effective stimulators of RANKL┽dependent osteoclastogenesis┻ )ndeed┸ in agreement with previous findings ゅにのょ┸ we observed that recombinant LOX in combination with RANKLギM┽CSF stimulated the formation of osteoclasts in vitro┸ compared to control ゅRANKLギM┽CSFょ ゅFig┻ のaょ┻ Additionally┸ LOX promoted a greater nuclear localization of NFATcな┸ the master regulator of osteoclastogenesis┸ than RANKLギMCSF alone ゅぱの vs 
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ぬどガ of positive nuclear staining┹ P ジ ど┻どなょ ゅFig┻ のbょ┻ LOX alone did not stimulate osteoclastogenesis ゅdata not shownょ┻ (ence┸ tumor┽secreted LOX and )L┽は were acting in concert to promote the generation of differentiated osteoclasts induced by RANKL┻  To determine whether LOX expression in (ctななは cells could also influence osteoblast differentiation┸ we treated primary calvarial mouse osteoblasts with the conditioned medium from Ctrl┸ LOXギ or LOX┽ (ctななは cells┻ We found that the conditioned medium from LOXギ(ctななは cells partially inhibited the formation of bone nodules and their mineralization┸ compared to conditioned media from Ctrl and LOX┽ (ctななは cells ゅFig┻ のc┽dょ┻  Collectively┸ our findings suggested that tumor┽derived LOX induces an imbalance between bone resorption and bone formation┸ which leads to bone destruction in vivo┻   
LOX primes tumor cells for dissemination to the bone marrow   To determine the role of LOX in the settlement of tumor cells in the bone marrow┸ animals injected with parental (ctななは cells were treated daily from D┽な to Dば with the conditioned medium from LOX┽ or LOXギ (ctななは cells┸ with or without tocilizumab or 
βAPN treatment┻ The bone marrow was then collected and placed in culture under antibiotic selection┸ enabling growth of tumor cells that have disseminated to the bone marrow ゅFig┻ はaょ┻  We recovered colony┽forming tumor cells in the bone marrow from ば out of など animals treated with the LOXギ conditioned medium┸ whereas only に out of ぱ animals treated with the LOX┽ conditioned medium had tumor cell colonies in the bone marrow ゅFig┻ はbょ┻ Moreover┸ the average number of colony┽forming tumor cells recovered from the bone marrow of the ば metastatic mice treated with the LOXギ conditioned medium was ね┽fold higher than that recovered from the に mice treated with the LOX┽ conditioned medium ゅFig┻ はbょ┻ The treatment of animals with βAPN completely 
 なば
blocked the stimulatory effects of LOX on incidence ゅな out of は animalsょ and number of colony┽forming tumor cells in the bone marrow ゅFig┻ はbょ┻ )n sharp contrast┸ tocilizumab did not inhibit LOX stimulatory effect on tumor cell dissemination ゅfig┻ はbょ┻  Thus┸ these data indicate that LOX ゅirrespective of )L┽はょ is crucially important in the settlement of tumor cells in the bone marrow┻  
LOX promotes tumor cell adhesion and survival  We have previously reported that LOX overexpression in breast cancer cells induces bone metastasis┸ a phenotype associated with its ability to induce the expression of a major epithelial┽to┽mesenchymal ゅEMTょ┽transcription factor┸ TWIST1 ゅぱょ┻ Additionally┸ we have shown that TWIST1 facilitates breast cancer bone metastasis formation ゅになょ┻  We therefore proceeded to explore whether LOX promoted tumor cell colonization in bone via induction of EMT┻ (ctななは cells expressed detectable levels of genes encoding for EMT┽inducing transcription factors┸ such as TWIST1 and SNAI1 ゅSupplementary Fig┻ Sのょ┻ LOX expression in (ctななは cells did not modify the morphological appearance of these cells and it did not modify TWIST1┸ SNAI1 or vimentin ゅVIM) expression ゅsupplementary Fig┻ Sのょ┸ indicating that LOX in colon cancer cells does not contribute to bone marrow colonization by promoting an EMT┻  Early steps of bone metastasis involve the attachment and survival of DTCs to and in the bone matrix ゅなねょ┸ two properties we examined using in-vitro assays┻ Collagens constitute ひどガ of the total protein content in bone┸ type┽) collagen being the most abundant bone extracellular matrix protein ゅにはょ┻ Cell attachment experiments to type┽) collagen were therefore performed using Ctrl┸ LOX┽ and LOXギ(ctななは cells┻ As shown in Fig┻ はc┸ there was a significant gain in the attachment of LOXギ(ctななは cells to collagen┸ compared to Ctrl (ctななは cells┻ The attachment of LOX┽deficient tumor cells was lower 
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than that observed with Ctrl (ctななは cells ゅFig┻ はcょ┻ )n contrast┸ the extent of attachment of (ctななは tumor cell lines to fibronectin was the same┸ irrespective of LOX expression levels ゅSupplementary Figure Sはょ┻ Using (ctななは cells silenced for LOX expression ゅLOX┽ょ as a control to measure baseline cell attachment to collagen┸ we conducted cell attachment experiments with LOXギ(ctななは cells┸ in the presence or absence of βAPN or tocilizumab┻ As shown in Fig┻ はc┸ βAPN abrogated the gain of attachment of LOXギ(ctななは cells to collagen ゅLOXギ βAPNょ┸ compared to that observed with untreated cells ゅLOXギょ or LOX+(ctななは cells treated with tocilizumab┻ LOX stimulated Akt┸ Src┸ and FAK phosphorylation in tumor cells previously attached to collagen ゅFig┻ はcょ┻ Additionally┸ 
βAPN ゅbut not tocilizumabょ inhibited stimulatory effect of LOX on Akt┸ Src┸ and FAK phosphorylation ゅFig┻ はcょ┻ (ence┸ these observations suggested that LOX activity is important to mediate CRC cell attachment to type┽) collagen┻    Once tumor cells seed in the bone marrow┸ they need to survive in this microenvironment┻ A relevant in vitro feature of CRC cell survival is their ability to grow as colonospheres ゅにばょ┻ We thus asked whether Ctrl┸ LOX┽┸ and LOXギ (ctななは cells could form colonospheres in serum┽free medium┻ )ndeed┸ LOXギ(ctななは cells formed a higher number of colonospheres than the two other (ctななは cell lines┸ and growth of LOXギ(ctななは cells as colonospheres was significantly inhibited in the presence of βAPN ゅSupplementary Fig┻ ば and data not shownょ┻ Thus┸ LOX can provide CRC cells with a survival advantage in the bone marrow┻  
Discussion  A large body of preclinical and clinical evidence has shown that LOX expression in tumors facilitates the progression of several cancers and the development of metastases 
 なひ
to distant organs┸ such as the lungs┸ liver┸ and brain ゅな┸に┸ね┸ば┸ひ┸などょ┻ )ndeed┸ LOX has been identified as an important regulator of hypoxia┽induced tumor progression via a ()F┽なα┽dependent mechanism in numerous cancer types ゅな┸ひ┽ななょ┻ Surprisingly┸ aside from a very recent report that hypoxia┽induced LOX promotes bone metastasis of breast cancer ゅなひょ┸ there was no evidence as to whether this is a generalised function┹ i.e┻ if tumor┽derived LOX participates in the development of bone metastasis in other cancer models┸ such as colon cancer┻ We have previously shown that LOX synergizes with ()F┽なα in promoting in vivo growth of colorectal cancers ゅにょ┻ )n the present study┸ we found that LOX was expressed by tumor cells in the bone marrow from CRC patients with bone metastases and that┸ irrespective of HIF-1α expression┸ tumor┽secreted LOX promoted settlement of CRC cells in the bone marrow and induced a robust expression of )L┽は by these tumor cells┻ )n turn┸ both LOX and )L┽は played a prominent role in enhancing RANKL┽dependent differentiation of mature osteoclasts┻ )n breast cancer┸ it has been shown that LOX stimulates the generation of differentiated osteoclasts through the activation of NFATcな ゅなひょ┻ LOX secreted from CRC cells also promoted the nuclear translocation of NFATcな in osteoclasts┻ Additionally┸ LOX inhibited osteoblast differentiation┸ thereby creating an imbalance between bone resorption and bone formation┻ Based on these findings we propose a model in which LOX supports CRC cell dissemination in the bone marrow and LOX┽driven )L┽は production by CRC cells impairs bone homeostasis┸ thereby promoting osteolytic lesion formation in vivo ゅFig┻ はdょ┻   (aving shown that tumor┽secreted LOX drives osteolytic lesion formation in vivo, we then attempted to determine the specific steps of bone colonization to which LOX functions are manifested┻ )t has been previously reported that LOX enhances the metastatic trait of breast tumors in animals by stimulating TWIST1 expression in tumor cells ゅぱょ┻ Additionally┸ LOX overexpression in breast cancer has been associated with 
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EMT of tumor cells ゅにぱょ┻ (ere┸ LOX overexpression in (ctななは cells did not modify the morphological appearance of these cells and it did not modify the expression of transcription factors TWIST1 and SNAI1┸ indicating that LOX in CRC cells did not contribute to tumor cell dissemination in bone by promoting an EMT┻ )nstead┸ our results established that LOX ゅirrespective of )L┽はょ is crucially important in the settlement of CRC cells in the bone marrow in vivo┻ Specifically┸ we showed that LOX directly plays a stimulatory role in the survival of CRC cells in the bone marrow by enhancing their attachment to collagen┻ This contention was supported by the fact that ゅiょ LOX activated the phosphorylation of Akt┸ FAK and Src in CRC cells thta were attached to collagen and ゅiiょ the blockade of LOX activity with βAPN inhibited both CRC cell attachment to collagen and Akt┸ FAK and Src phosphorylation┻ (ere┸ cell attachment experiments to solid┽phase adsorbed collagen were conducted over な hour┸ at which time collagen fibers are still disorganized ゅなぬょ┻ Thus┸ irrespective of its ability to crosslink collagen fibers ゅなょ┸ LOX specifically stimulated phosphorylation of Akt┸ Src┸ and FAK in CRC cells attached to collagen┻ (ow LOX activity activates Akt┸ Src┸ and FAK remains unclear┻ )t has been shown that LOX enhances integrin┽associated signaling pathways such as FAK and Src ゅな┸ね┸はょ┻ Additionally┸ integrins mediate CRC survival through Akt ゅにひょ and we have previously reported that LOX activates Akt in CRC cells ゅにょ┻ Therefore┸ it is conceivable that some integrin┽mediated mechanisms are involved in promoting ゅdirectly or indirectlyょ the effect of LOX on CRC cell adhesion to collagen┻ Our findings do not preclude the possibility that other members of the LOX family could contribute to the dissemination of CRC cells in the bone marrow┻ (owever┸ endogenous mRNA levels of LOXL1┸ LOXL2┸ LOXL3 and LOXL4 in (ctななは cells were only barely detectable ゅにょ┸ and LOX overexpression in these tumor cells did not modify expression levels of other LOX family members ゅSupplementary Table Sぬょ┻ 
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 Although overt bone metastasis is rare in colon cancer and frequent in breast cancer┸ the detection rate of DTCs in the bone marrow from CRC patients is comparable to what is observed in breast cancer ゅなのょ┻ )t seems therefore that colon cancer DTCs should harbor a mechanism to grow out┸ but this appears to be somehow blocked in colon cancer patients┻ Only の CRC patients with bone metastases were studied here┻ (owever┸ all of them had LOX┽positive tumor cells in the bone marrow┻ Additionally┸ LOX overexpression endowed CRC cells with full competence for aggressive colonization in bone in vivo┻ Environments that are rich in type┽) collagen may be critical for DTCs┸ promoting their transition from dormancy to metastatic growth ゅぬどょ┻ Given the role of LOX in mediating CRC cell attachment to collagen and survival in the bone marrow┸ it is conceivable that LOX participates to metastatic outgrowth of DTCs┻   )n conclusion┸ our findings collectively show that LOX supports CRC cell dissemination in the bone marrow and they reveal a novel mechanism through which LOX┽driven )L┽は production by CRC cells impairs bone homeostasis┻ We believe this is a crucially important observation┸ which supports targeting LOX for metastasis prevention┻ 
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Figure legends 
Figure 1. LOX expression in pairs of human primary colorectal carcinoma and 
their matching bone metastasis. )mmunohistochemistry was performed using ぬ pairs of patients╆ tumor specimens┻ A strong immunostaining for LOX was observed in neoplastic cells ゅarrowsょ and┸ to a less extent┸ in the desmoplastic tumor stroma┻ )n bone ゅこょ┸ LOX was observed in osteocytic lacunae┻ Scale bar┺ な┽mm┻ 
 
Figure 2. High LOX expression in colorectal cancer cells promotes osteolytic lesion 
formation in vivo. ゅaょ Whole body bioluminescence imaging of animals at day ぬな after intra┽arterial inoculation of luciferase┽expressing (ctななは cells┻ Ctrl┺ parental (ctななは cells┻ LOXギ┺ LOX┽overexpressing (ctななは cells┻ Ctrl【()F┽なα┽┺ shRNA┽HIF1α┽expressing (ctななは cells┻ LOXギ【()F┽なα┽ ┺ LOX┽overexpressing (ctななは cells silenced for HIF-1α┻ The images shown are examples that best illustrate data obtained for each group┻ ゅbょ Quantification of the area of osteolytic lesions ゅmmにょ on radiographs on day ぬな after tumor cell inoculation┻ Inset ┺ Representative radiographs of hind limbs with osteolytic lesions ゅarrowsょ┻ ゅcょ Left-hand panels┺ Representative radiographs of hind limbs from mice bearing (ctななは┸ (Tにひ or LSなばねTr colorectal tumors┻ Ctrl┺ parental tumor cells┹ LOXギ┺ LOX┽overexpressing tumor cells┹ LOX┽┺ shRNA┽LOX┽expressing tumor cells┻ Right-
hand panels: Quantification of the area of osteolytic lesions ゅmmにょ on radiographs at day ぬの after tumor cell inoculation┻ (d) Upper panels: Goldner╆s trichrome staining of tissue sections of tibial metaphysis from tumor┽bearing animals┻ Bone is stained green┸ whereas bone marrow and tumor cells are stained red┻ The doted line delimits the extent of tumor burden┻ Lower panels┺ TRAP┽stained metastatic bone tissue sections┻ Osteoclasts are stained red ゅarrowsょ┻ All images were obtained from different mice on day ぬの after tumor cell inoculation┻ The images shown are examples that best illustrate 
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LOX╆s effects on bone destruction and tumor burden┻ Scale bar┺ ど┻な mm┻ Data are mean グ SD┻ こ┸ここ┸こここ┺ p ジ ど┻どの┸ ど┻どな or ど┻どどな┸ respectively┻ NS┺ not significant┻  
Figure 3. Systemic delivery of tumor-secreted LOX enhances osteolysis and tumor 
cell outgrowth in the bone marrow. ゅaょ Schematic representation of the experimental protocol┻ Parental (cななは cells were inoculated intra┽arterially to Balb【c nude mice┻ Animals received a の┽week daily treatment with the conditioned medium from LOX┽ or LOXギ(ctななは cells┸ starting one day before tumor cell inoculation┻ Tumor┽bearing mice were analyzed by radiography ゅRXょ at day ぬの after tumor cell inoculation┸ then culled and the bone marrow was collected for tumor cell colony assays┻ ゅbょ Quantification of osteolytic lesions ゅmmにょ on radiographs┻ Inset┺ Representative radiographs of hind limbs with osteolytic lesions ゅarrowsょ from animals treated with the conditioned medium of LOX┽ or LOXギ (cななは cells┻ ここ┺ p ジ ど┻どな ゅcょ Graphs showing the total number of tumor cell colonies formed in the bone marrow of each mouse treated with the LOX┽ or LOXギ conditioned medium┻ Representative images of tumor cell colonies are shown for each group┻   
Figure 4. LOX-driven IL-6 production by colorectal cancer cells stimulates 
osteoclastogenesis. ゅaょ In vitro osteoclast differentiation of murine bone marrow cells treated with M┽CSFギRANKL in combination with the conditioned medium from Ctrl┽┸ LOX┽ or LOXギ(ctななは cells┻ The conditioned medium from LOXギ(ctななは cells treated with 
βAPN was also tested┻ Mature osteoclasts were quantified as multinucleated ゅmore than ぬ nucleiょ┸ TRAP┽positive cells┻ ゅbょ EL)SA measurement of )L┽は in the conditioned medium from Ctrl┽┸ LOX┽┸ LOXギ or LOXギ【βAPN (ctななは cells┻ ゅcょ )mmunoblot analysis of phosphorylated STATぬ in Ctrl┽┸ LOX┽┸ and LOXギ(cななは cells┸ treated or not treated with 
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tocilizumab┻ Graphs show intensities of phosphorylated STATぬ relative to total STATぬ┻ Tubulin was used as a control for equal loading┻ (d) Correlation analysis of LOX and IL-6 expression intensities from ば databases on colon cancer ゅn サ な┸なねは patientsょ┻ (e) Effect of exogenous )L┽は ゅなど ng【mlょ on osteoclastogenesis induced with M┽CSFギRANKL in combination with the conditioned medium of LOX┽ (ctななは cells┸ compared with that of LOXギ(ctななは cells┻ (f) Effects of the anti┽)Lは receptor antibody tocilizumab ゅなどど ng【mlょ and of β┽APN ゅぬのどµMょ on RANKL┽dependent osteoclastogenesis in the presence of the conditioned medium of LOXギ(ctななは cells┻ こ┸ここ┺ p ジ ど┻どの or ど┻どな┸ respectively┻  
Figure 5. LOX stimulates osteoclastogenesis and inhibits osteoblastogenesis. (a) Recombinant LOX ゅrLOX┹ なのど ng【mlょ enhanced RANKL┽dependent osteoclast differentiation┻ (b) Conditioned medium from LOXギ(cななは cells promoted the nuclear translocation of NFATcな in osteoclasts┸ compared to conditioned medium from parental (ctななは cells ゅCtrlょ┻ Nuclei are stained blue with DAP)┻ (c) and (d) In vitro differentiation of primary mouse calvaria cells cultured in osteogenic conditions with conditioned media from Ctrl┸ LOX┽ and LOXギ(ctななは cells┻  Bone mineralized nodules ゅstained black with von Kossa stainingょ were counted under light microscopy┻ Data are mean グ SD┻ こ┸ここ┺ 
P ジ ど┻どの and ど┻どな┸ respectively┻  
Figure 6. Systemic delivery of tumor-secreted LOX promotes the settlement of 
colorectal cancer cells in the bone marrow. ゅaょ Schematic representation of the experimental protocol┻ Parental (cななは cells were inoculated intra┽arterially to nude mice┸ then animals were treated with conditioned media of LOX┽ or LOXギ(ctななは cells ゅtreated or not treated with βAPN or tocilizumabょ┻ ゅbょ Graphs showing for each group the average number of tumor cell colonies recovered from the bone marrow┻ Each bar 
 にひ
corresponds to a single mouse┻ Data are mean グ SD┻ ここ┺ P ジ ど┻どな┻ ゅcょ Attachement of Ctrl┽┸ LOX┽ and LOXギ(ctななは cells to increasing concentrations of collagen┻ Inset┺ effect of 
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Table 1. Effects of LOX overexpression or silencing in (ctななは colorectal cancer cells on bone metastasis formation in animals┻ 
Cell 
line 
Histomorphometry TRAP staining 
 BV【TV ゅガょ p TuV【STV ゅガょ p OC┻S【BS ゅガょ p 
Ctrl には┻の グ に┻ぬ ゅnサぱょ ┽ ひ┻ぱ グ は┻ね ゅnサぱょ ┽  ぬな グ ね┻な ゅnサのょ ┽ 
LOXギ なぬ┻ひ グ に┻に ゅnサぱょ 0.0006 のば┻は グ の┻の ゅnサぱょ 0.0016 ばぬ グ は ゅnサばょ 0.0017
LOX┽ にぱ┻ぬ グ に┻ひ ゅnサばょ 0.53 に┻は グ に┻な ゅnサばょ 0.33 なひ グ ぱ┻ぬ ゅnサぬょ 0.09
Values are mean グ SD┻ Values of p ゅtwo sidedょ are for pairwise comparison with the control group ゅCtrlょ using the Mann┽Whitney U test┻  BV【TV サ bone volume┽to┽tissue volume ratio┹ TuV【STV サ tumour volume┽to┽total soft tissue volume ratio┹ OC┻S【BS サ active osteoclast┽resorption surface per trabecular bone surface┻┹ TRAP サ tartrate┽resistant acid phosphatase┻   
